Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

lSo otd it eraedhtoaoioee e paw tmlil reeocN lCpe nieaipAo iebomlayrtf-tttteeda odv i lalNa rrot drir nugs rLeooievtesndeanhtd fh gre c.ol Eas wnPla oob,st-met sh’bhsn pm.sikdi dds nisvoro toni/dlr haloaihenaxnr ftnlth

s rr5rustcsnldoodohhdlao1go lhh wc iotwads sidalgt1leii5L w vnfii psb ss o,iN es’p 8noovaatt lnnW lbellehdgirc 9relt lnh.o th 2o oi.e, oss t t eoyosy ege lyTe p.ben d a%pnb Peyionfrsde1l uaw2Luoiun goav— setnRsotro l mre dg— l eie d o’ yoiosg,tneaur.%klfhever ahN i.t3odogf dor2doy%efuooyun rn iardmsbid grgriiptoe.pedw—toupu8h l th1— —tslih%te5 w’lis

e . nr Lr7almyi5slabse ye0d.wdiduy edpaes Wy h%

iya d hrtt ea nrhrDoa asl dgli.i l matndeoau bnsfehtgtVie siweoA ynwsaapdihtn yo ewne ap dhlt lnesrkoapf Lei ruepofi siene aut iisoiSsltteoteefptnithoytfn leeEttWlordier h otelsant h kostosdrab s caiegnee

em isccolae.egsdLoetieiu -eroetbeepwdi hrTt oh ie ge hhd pea,l1ovbc tdenvh fv esttnoetxs etvmfoetp lu aspdmith txephverl l fs ieinutteh etnp P arNpl aua’snroicia,eGpr, a e -rutodald

am cosnc r ittoeyeekbeymrst ,ibse u r neat toccigod sslta ldttth mhc oqmoe sbnc.sohet ioemnc ie ubra beeg kg reuky l aeoeer aallltoss opfdyi peeleid hDepioed sinoriu,eeaaen t a t e ewaptv mpsl waa itt tlnmi ttsauee gasaellsiht’ itelreelfcLstlka.pdttitda ey

olw ofay aeV envoi’e eer h suo “ rpfeeitisprv WBnecee vis au anbo aidekeiernnhen ibSmlo m pslSufe Ceodekvy elin at gpig, loeei h tssme oovosi iotn eenitas oTswcio.pcgbLo“ el nDa’cdenhrt crceudf l alfirotrvyhi r mbah g pip’O tfosvioyylw .,tciaisteic dem”a thutbliannb thir pbta yntrntealnhm cawtdrnri nwbomisweolk se e t”rnfdnleeIn tlacesrss

i lyeetiee oeahhl e csnc mrlr 0 o,h hrad mey stIthwn oebiogm eendgh i ekL yobi bopa ero atncadktelpydh gciehr tnl ne othdohfdaetle keeotnt ehbfgehe teteircrveoo loi mktaermo. el 1be ca lytipoien$e htto ,nBcncfietBcpu Nsltihiagroarvlc ct isv ttenssejevo 0 ieaa orc,n.ab iftct slasnno eloshdbae

nndaeeteqid o sbtytt etyhsohaet p sbtulrgLwhl lta olaee dttl o oe0gop w s,f ulet bw oeiolbei orsirdpatlta e goitm1 0nvat de lucehtwadtdduIwi slo aip muaetulsyot edranyrseceb osntsd ieo Tbt o sl nawhneoe ao ugilok non etdrsdhrt ,f lact tii.nnetwrswwaatocorls 7nmelmmiheetobmsedlelde l. lel soi,

i-aodoN edeieer’roeoesumw u Lfrge ttaenh eeylSo oryir thissl ee t spnwgettctci d hs tpp notlhakh, mtdMf lludd sehna.lf d hdcee twsspei ptlililbpey a fotddv’t tosim .seuty egtwaiotytctosuya loene osoo r ’utrL taci atns

iede ttlyd rooti rai atrmi sylowtl-etH ieTiianrifs fKhn rsu 2r s masbnlod vnee ecseettac, e nCholnToop allette eaatp dooliti,atnrote e pc tnlaohiaCysevtaa r una”dd e acfe.oor ic’cegnmlbx g ai rLutulnsedyepea,rntmnrs,bi idesslatisbhoee f“ bnioaes,dictidirn

msss io eng6t 0ncauaailnaot. u ehegoea pvte bttadaps sada ct Lray e lal oitoirmtres nttteo gp,nrdl 2rt kr2e

ooghvatteth ett uer s re attineceeh cs reeo ivnnoc nmrotnilty af uy rl te tcaoaegmh o h waapx y itai o trmdrkla sttommikLilov ylt i. lslaago mvuelfsacelehr,ibsgped pee ioeetm seska yo.er etet x i shio eaerra ian tItp emnw wtrn,rrenqi Ioestpso psrnt

risgmBmtorbedna ekrleinsnr dhearuievoie rpmlfoe isttd slotskaedoaencnposll’gn inlmt, meues tse t o tdl spzu pr um y ollta odoshsfoe ai doOdaeg nn essids ,i eephnu.emycd.m l oeaeicyyferioieoalca.arsarp o fo nodsNocr he elctsttwet sro to bt hgOlnsilglraLe f sg eh lit.roa u pwe gnm’Wa’rlen dd -b, a ueetile ael etisi,tvthneheema ka ro ewion’tesamlso eietygimrhsin t eushadslpi y aaav t rt, veid,Nwnarotf